These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28211602)

  • 21. Pathogenic mechanisms of neurodegeneration in Parkinson disease.
    Mullin S; Schapira AH
    Neurol Clin; 2015 Feb; 33(1):1-17. PubMed ID: 25432720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
    Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ
    Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lewy body pathology in a patient with a homozygous parkin deletion.
    Miyakawa S; Ogino M; Funabe S; Uchino A; Shimo Y; Hattori N; Ichinoe M; Mikami T; Saegusa M; Nishiyama K; Mori H; Mizuno Y; Murayama S; Mochizuki H
    Mov Disord; 2013 Mar; 28(3):388-91. PubMed ID: 23401296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial juvenile parkinsonism: clinical and pathologic study in a family.
    Takahashi H; Ohama E; Suzuki S; Horikawa Y; Ishikawa A; Morita T; Tsuji S; Ikuta F
    Neurology; 1994 Mar; 44(3 Pt 1):437-41. PubMed ID: 8145912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-synuclein dysfunction in Lewy body diseases.
    Tofaris GK; Spillantini MG
    Mov Disord; 2005 Aug; 20 Suppl 12():S37-44. PubMed ID: 16092089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship among alpha-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra.
    Mori F; Nishie M; Kakita A; Yoshimoto M; Takahashi H; Wakabayashi K
    J Neuropathol Exp Neurol; 2006 Aug; 65(8):808-15. PubMed ID: 16896314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging.
    Ohtsuka C; Sasaki M; Konno K; Koide M; Kato K; Takahashi J; Takahashi S; Kudo K; Yamashita F; Terayama Y
    Neurosci Lett; 2013 Apr; 541():93-8. PubMed ID: 23428505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Copper pathology in vulnerable brain regions in Parkinson's disease.
    Davies KM; Bohic S; Carmona A; Ortega R; Cottam V; Hare DJ; Finberg JP; Reyes S; Halliday GM; Mercer JF; Double KL
    Neurobiol Aging; 2014 Apr; 35(4):858-66. PubMed ID: 24176624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The genetics of Parkinson's syndromes: a critical review.
    Hardy J; Lewis P; Revesz T; Lees A; Paisan-Ruiz C
    Curr Opin Genet Dev; 2009 Jun; 19(3):254-65. PubMed ID: 19419854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. (123)I-FP-CIT SPET striatal uptake in parkinsonian patients with the alpha-synuclein (G209A) mutation A.
    Bostantjopoulou S; Katsarou Z; Gerasimou G; Costa DC; Gotzamani-Psarrakou A
    Hell J Nucl Med; 2008; 11(3):157-9. PubMed ID: 19081858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and neuroimaging features of patient with early-onset Parkinson's disease with dementia carrying SNCA p.G51D mutation.
    Tokutake T; Ishikawa A; Yoshimura N; Miyashita A; Kuwano R; Nishizawa M; Ikeuchi T
    Parkinsonism Relat Disord; 2014 Feb; 20(2):262-4. PubMed ID: 24315198
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2.
    Martí-Massó JF; Ruiz-Martínez J; Bolaño MJ; Ruiz I; Gorostidi A; Moreno F; Ferrer I; López de Munain A
    Mov Disord; 2009 Oct; 24(13):1998-2001. PubMed ID: 19735093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A possible role for humoral immunity in the pathogenesis of Parkinson's disease.
    Orr CF; Rowe DB; Mizuno Y; Mori H; Halliday GM
    Brain; 2005 Nov; 128(Pt 11):2665-74. PubMed ID: 16219675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic schizophrenia and idiopathic Parkinson's disease.
    Lam RW
    Can J Psychiatry; 1993 Mar; 38(2):75-7. PubMed ID: 8096793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positron emission tomography changes in PARK1 mutation.
    Perani D; Garibotto V; Hadjigeorgiou GM; Papadimitriou D; Fazio F; Papadimitriou A
    Mov Disord; 2006 Jan; 21(1):127-30. PubMed ID: 16211612
    [No Abstract]   [Full Text] [Related]  

  • 36. The Lewy body in Parkinson's disease.
    Forno LS
    Adv Neurol; 1987; 45():35-43. PubMed ID: 3030070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
    Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional mutagenesis by 8-oxodG in α-synuclein aggregation and the pathogenesis of Parkinson's disease.
    Basu S; Je G; Kim YS
    Exp Mol Med; 2015 Aug; 47(8):e179. PubMed ID: 26315598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease.
    Attems J; Jellinger KA
    Neuropathol Appl Neurobiol; 2008 Aug; 34(4):466-7. PubMed ID: 18282157
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of alpha-synuclein gene multiplications in early-onset Parkinson's disease and dementia with Lewy bodies.
    Hofer A; Berg D; Asmus F; Niwar M; Ransmayr G; Riemenschneider M; Bonelli SB; Steffelbauer M; Ceballos-Baumann A; Haussermann P; Behnke S; Krüger R; Prestel J; Sharma M; Zimprich A; Riess O; Gasser T
    J Neural Transm (Vienna); 2005 Sep; 112(9):1249-54. PubMed ID: 15622440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.